Pancreatic Cancer

Because pancreatic cancer is difficult to diagnose early, many do not find out they have it until it is well advanced and surgery is not possible. Discover more about pancreatic cancer, including risk factors, screening and diagnosis, symptoms and treatment.

Most Recent

  • Why Doctors Order the CA 19-9 Tumor Marker Test to Confirm or Rule Out Pancreatic Cancer
    There have been significant advances in the understanding of pancreatic cancer at the molecular level and in the treatment of early-stage tumors. A blood test for pancreatic cancer is possible by measurement of serum CA 19-9, which can be a useful biomarker for the disease.
  • Final Stages of Pancreatic Cancer
    Unfortunately, many patients are not diagnosed until the last stages of pancreatic cancer. In stage IV of the disease, pain maintenance is the main concern.
  • Taxotere vs. Taxol in the Treatment of Cancer of the Pancreas
    The risks of Taxol and Taxotere are based on the health of the patient. Most patients have limited side effects below the maximum tolerated dose. The benefits include increased survival time and slower disease progression.
  • Pain Relief for Pancreatic Cancer Patients
    Pancreatic cancer is often detected late and has a poor prognosis. Its most prominent symptom is severe abdominal and back pains. Learn more about pancreatic cancer pain relief and how to improve the quality of one’s remaining life.
  • The Development of uPA Targeted Therapy for Cancer
    The uPA-uPAR enzyme system is involved in many malignancies, including pancreatic cancer. However progress in therapeutic targeting have been slow. Now, antibody therapies show potential to enter the clinic, allowing researchers to investigate the potential of uPA targeted therapy for cancer.
  • Cutting Edge Treatments for Pancreatic Cancer
    Cutting edge treatments for pancreatic cancer are used to produce more effective results. Several surgical procedures, radiation therapy and chemotherapy are the key treatment options. Some patients may also participate in ongoing clinical trials for pancreatic cancer.
  • Survival Rates for Pancreatic Cancer
    Pancreatic cancer is one of the most lethal cancers there is. This article discusses pancreatic cancer survival rates and elements that can affect these.
  • Pancreas Tumor Markers
    There are a number of pancreas cancer tumor markers which can be used in the diagnosis and management of pancreatic cancer including CA19-9 and galactosyltransferase II.
  • Tumors in the Pancreatic Duct
    Tumors in the pancreatic duct are mostly malignant and remain to be some of the most deadly cancers because they are difficult to diagnose and do not improve much with treatment. Learn more about these tumors which are affecting more people in the United States, how they are diagnosed and treated.
(1 of 2)